(Q426132)

English

tolvaptan

selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone

  • OPC-41061
  • Samsca®

Statements

0 references
448.155 dalton
1 reference
C₂₆H₂₅ClN₂O₃
1 reference
CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C
1 reference
1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
Tolvaptan
0 references

Identifiers

1 reference
28 October 2019
Tolvaptan (English)
10 May 2021
691-537-5
1 reference
27 December 2018
N-(4-{[(5S)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl}-3-methylphenyl)-2-methylbenzamide (English)
CAS no.: 150683-30-0 (English)
1 reference
27 December 2018
N-(4-{[(5S)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl}-3-methylphenyl)-2-methylbenzamide (English)
CAS no.: 150683-30-0 (English)
0 references
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit